等待开盘 07-01 09:30:00 美东时间
+0.020
+5.87%
今日重点评级关注:Ascendiant Capital:维持NextTrip"买入"评级,目标价从7美元升至7.5美元;Maxim Group:维持Zevra Therapeutics"买入"评级,目标价从25美元升至35美元
06-11 09:55
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Ascendiant Capital cut the price target for Surgepays Inc (NASDAQ:SURG) from $5 to $3.5. Ascendiant Capital an...
06-10 20:24
Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and lowers the price target from $5 to $3.5.
06-10 17:48
SurgePays, Inc. (NASDAQ:SURG) ("SurgePays" or the "Company"), a fintech and mobile virtual network operator (MVNO) delivering prepaid wireless and financial products to approximately 138 million subprime consumers in the
06-05 21:31
Surgepays (NASDAQ:SURG) released first-quarter financial results and hosted an ...
05-15 23:34
Surgepays (NASDAQ:SURG) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.19) by 168.42 percent. This is a 34.21 percent decrease over losses of $(0.38) per share from the
05-15 21:01
Companies Reporting Before The Bell • Traws Pharma (NASDAQ:TRAW) is expected to...
05-15 19:11
The CNN Business Fear & Greed Index, a measure of market sentiment, improved slightly on Thursday but remains in the Greed zone at 66.1.
05-15 14:01
US stock futures down, key stocks to watch: RBC Bearings, Applied Materials, Surgepays, Nu Holdings & Figma. Figma reports strong Q1 results.
05-15 13:42
Alpha Modus Holdings, Inc. ("Alpha Modus") (NASDAQ:AMOD), through its subsidiary Alpha Modus Financial Services, LLC ("AMFS"), and SurgePays, Inc. (NASDAQ:SURG) ("SurgePays"), today announced the execution of a
05-07 20:19